Vertaling van "in this advisory report " (Frans → Nederlands) :

considérations sur les différentes méthodes utilisées pour la désinfection des piscines In this scientific advisory report to policy makers, the Superior Health Council reflects on chlorine and alternative methods for swimming pool disinfection and infection control and, in doing so, focuses on the particular target group of young infants (0-12 month-old baby swimmers).
In this scientific advisory report to policy makers, the Superior Health Council reflects on chlorine and alternative methods for swimming pool disinfection and infection control and, in doing so, focuses on the particular target group of young infants (0-12 month-old baby swimmers).

In this science - policy advisory report, the Belgian Superior Health Council provides recommendations regarding infection control (Aspergillus and other mould, Legionella, etc) throughout a hospital design and construction project, as well as renovation works and other
In this science - policy advisory report, the Belgian Superior Health Council provides recommendations regarding infection control (Aspergillus and other mould, Legionella, etc) throughout a hospital design and construction project, as well as renovation works and other technical interventions carried out in health facilities; these recommendations are intended for the internal and external players involved in these activities.

CSS 8838: Peptide Receptor Radionuclide Therapy “In this advisory report, the Superior Health Council provides a risk assessment (efficacy, toxicity, safety and radioprotection) for Peptide Receptor Radionuclide Therapy (PRRT) with Lutetium-177 and Yttrium-90 for patients diagnosed with gastroenteropancreatic neuroendocrine tumours.
HGR 8838: Peptide Receptor Radionuclide Therapy “In this advisory report, the Superior Health Council provides a risk assessment (efficacy, toxicity, safety and radioprotection) for Peptide Receptor Radionuclide Therapy (PRRT) with Lutetium-177 and Yttrium-90 for patients diagnosed with gastroenteropancreatic neuroendocrine tumours.

In this scientific advisory report, the Superior Health Council provides an expert opinion on screening for cardiac abnormalities that predispose to sudden cardiac death among the adolescents and young adults
In this scientific advisory report, the Superior Health Council provides an expert opinion on screening for cardiac abnormalities that predispose to

In this scientific policy advisory report, the Superior Health Council of Belgium provides some recommendations for the prevention and treatment of anaphylaxis after classical parenteral vaccination of infant, child and adolescent.
Preventie en aanpak van anafylactische shock bij vaccinatie van kinderen In this scientific policy advisory report, the Superior Health Council of Belgium provides some recommendations for the prevention and treatment of anaphylaxis after classical parenteral vaccination of infant, child and adolescent.

In this science-policy advisory report, the Superior Health Council provides an analysis of palm oil’s nutritional qualities and the possible health effects of a high consumption.
In this science-policy advisory report, the Superior Health Council provides an analysis of the nutritional qualities of palm oil and the possible health effects of a high consumption.

Sur base des méthodologies EuSANH et CSS, comparées à deux autres institutions scientifiques, à savoir le National Institute for Health and Clinical Excellence (NICE) et le Centre Fédéral d’expertise en soins de santé (KCE), le rapport identifie 8 étapes clés pour la production d’un avis ou Scientific Policy Advisory Report (SPAR):
Op grond van de EuSANH- en HGR- methodologieën, vergeleken met twee andere wetenschappelijke instellingen, te weten het National Institute for Health and Clinical Excellence (NICE) en het Federale kenniscentrum (KCE), onderscheidt het rapport 8 sleutelfasen voor het uitwerken van een advies of Scientific Policy Advisory Report (SPAR):

79,138 Workforce counts: better dataa on the supply side available, but data on the need side still lacking No indicators of the needs have been defined yet in this report, but the reflection should continue on this topic.
An example of micro data is a recent transparency in ambulatory supplements as well as in private hospital large-scale European nursing workforce study based on survey data.

This release contains forward-looking information that involves substantial risks and uncertainties regarding Prevenar 13, including its potential benefits; and the success of the AMC project for vaccines. Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; whether and when regulatory authorities in countries where regulatory applications for Prevenar 13 may be pending or may be submitted will approve such applications and their decisions regarding labeling and other matters that could affect its availability or commercial potential; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009, and in its reports on Form 10-Q and Form 8-K.
Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; whether and when regulatory authorities in countries where regulatory applications for Prevenar 13 may be pending or may be submitted will approve such applications and their decisions regarding labeling and other matters that could affect its availability or commercial potential; and competitive developments.